Radiotherapy and anthracyclines - cardiovascular toxicity

about

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis

P2860

Q33728180-BCA8AB09-C80F-457C-85B1-E19104DA1C1D Q58775872-904D1BF6-9E41-4C9C-A8E5-9A7EA5AF4436

P2860

Radiotherapy and anthracyclines - cardiovascular toxicity

Item

http://www.wikidata.org/entity/Q35648956

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Radiotherapy and anthracyclines - cardiovascular toxicity

@ast

Radiotherapy and anthracyclines - cardiovascular toxicity

@en

type

Item

label

Radiotherapy and anthracyclines - cardiovascular toxicity

@ast

Radiotherapy and anthracyclines - cardiovascular toxicity

@en

prefLabel

Radiotherapy and anthracyclines - cardiovascular toxicity

@ast

Radiotherapy and anthracyclines - cardiovascular toxicity

@en

P1476

Radiotherapy and anthracyclines - cardiovascular toxicity

@en

P2093

Dagmara Mozdzanowska

http://www.w3.org/2001/XMLSchema#string

Marek Woźniewski

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials

Unusual radiologic findings in the thorax after radiation therapy.

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy.

Cardiac dysfunction after cancer treatment.

Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: dental implications.

Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.

P304

93-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2014.40108

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274131135

http://www.w3.org/2001/XMLSchema#string

P698

26034385

http://www.w3.org/2001/XMLSchema#string

P932

4444437

http://www.w3.org/2001/XMLSchema#string

Radiotherapy and anthracyclines - cardiovascular toxicity

about

P2860

P2860

Radiotherapy and anthracyclines - cardiovascular toxicity

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932